Acadia Pharmaceuticals | ACAD - Capitalización De Mercado

Precio De Mercado
20.61
Cambio Diario
-0.66 -3.10%
Mensual
-10.20%
Anual
17.77%
Q1 Expectativa
19.99




Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
ALKERMES USD 4.62B 333M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cara Therapeutics USD 28M 11M 2024-12
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Cytokinetics USD 7.77B 1.19B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Incyte USD 19.39B 2.83B 2025-12
J&J USD 500.24B 67.44B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Prothena USD 525M 198M 2025-09
PTC Therapeutics USD 6.1B 1.22B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12